转染技术市场－全球产业规模、份额、趋势、机会和预测，按转染方法、产品、应用、技术、地区和竞争格局划分，2020-2030年预测

2024年全球转染技术市场规模为30.3亿美元，预计2030年将以9.61%的复合年增长率成长至52.5亿美元。转染技术涵盖将外源核酸（例如DNA或RNA）导入真核细胞的方法，从而实现基因改造，应用于各种研究、治疗和生物生产领域。该市场的成长主要受全球生命科学研究领域的大量投资、基因和细胞疗法需求的不断增长、疫苗研发的进步以及功能基因组学计划的扩展等因素驱动，而所有这些都需要高效的核酸递送技术。

主要市场驱动因素

全球转染技术市场主要受两大关键因素影响：一是细胞和基因疗法需求的不断增长，二是转染方法和递送系统的持续技术进步。不断扩展的细胞和基因疗法研发管线直接需要强大且高效的核酸递送工具，这对于这些先进治疗产品的研发和最终商业化至关重要。

主要市场挑战

阻碍市场扩张的一大挑战源自于某些转染方法固有的细胞毒性和效率差异。这些问题直接影响细胞活力和检测的可重复性，导致实验失败率上升、研发週期延长，以及昂贵试剂和人力的大量浪费。

主要市场趋势

与先进基因编辑技术的整合代表了转染技术的重大革新，它超越了单纯的遗传物质导入，实现了细胞内精准靶向的基因组修饰。透过转染方法有效地递送CRISPR-Cas系统等先进基因编辑工具，对于加速新型治疗应用和功能基因组学的研究至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球转染技术市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 透过转染方法（共转染、电穿孔、阳离子脂质体转染、脂质体转染、核转染、体内转染）
  • 依产品分类（试剂、仪器、其他）
  • 依应用领域（病毒生产、蛋白质生产、基因沉默、干细胞重编程和分化、稳定细胞株建构、治疗药物传递、生物医学研究、其他）
  • 依技术分类（物理转染、生化转染、病毒载体转染）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美转染技术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲转染技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区转染技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲转染技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲转染技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球转染技术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Promega Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Roche Molecular Systems, Inc.
• QIAGEN NV
• Inovio Pharmaceuticals
• Mirus Bio LLC
• Takara Bio Inc.
• SignaGen Laboratories
• MaxCyte, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Transfection Technologies Market, valued at USD 3.03 Billion in 2024, is projected to experience a CAGR of 9.61% to reach USD 5.25 Billion by 2030. Transfection technologies encompass methods for introducing exogenous nucleic acids, such as DNA or RNA, into eukaryotic cells, enabling genetic modification for various research, therapeutic, and bioproduction applications. The market's growth is primarily driven by substantial global investments in life sciences research, escalating demand for gene and cell therapies, advancements in vaccine development, and expanding functional genomics initiatives, all requiring efficient nucleic acid delivery.

Key Market Drivers

The Global Transfection Technologies Market is significantly influenced by two critical factors: the growing demand for cell and gene therapies and continuous technological advancements in transfection methods and delivery systems. The expanding pipeline of cell and gene therapies directly necessitates robust and efficient nucleic acid delivery tools, crucial for the research, development, and eventual commercialization of these advanced therapeutic products.

Key Market Challenges

A significant challenge impeding market expansion stems from the inherent cytotoxicity and variable efficiency associated with certain transfection methods. These issues directly compromise cell viability and assay reproducibility, leading to increased experimental failures, extended research and development timelines, and substantial wastage of costly reagents and labor. Compromised cell viability necessitates repeated experiments, driving up operational expenditures for biopharmaceutical companies engaged in drug discovery and therapeutic development. Similarly, inconsistent transfection efficiency results in unreliable data, requiring extensive validation and re-evaluation, thereby slowing the progression of promising candidates from preclinical stages to clinical trials.

Key Market Trends

The integration with advanced gene editing technologies represents a pivotal evolution in transfection, moving beyond mere genetic material introduction to enabling precise and targeted genomic modifications within cells. The effective delivery of advanced gene editing tools, such as CRISPR-Cas systems, by transfection methods is instrumental in accelerating research for novel therapeutic applications and functional genomics. This integration facilitates the correction of specific disease-causing mutations and precise modulation of gene expression. The expanded utility in these highly targeted applications amplifies the demand for sophisticated delivery systems that ensure high efficiency, cell viability, and minimal off-target effects.

Key Market Players

• Promega Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Roche Molecular Systems, Inc.
• QIAGEN NV
• Inovio Pharmaceuticals
• Mirus Bio LLC
• Takara Bio Inc.
• SignaGen Laboratories
• MaxCyte, Inc.

Report Scope:

In this report, the Global Transfection Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transfection Technologies Market, By Transfection Method:

• Cotransfection
• Electroporation
• Cationic Lipid Transfection
• Lipofection
• Nucleofection
• In Vivo Transfection

Transfection Technologies Market, By Product:

• Reagent
• Instrument
• Others

Transfection Technologies Market, By Application:

• Virus Production
• Protein Production
• Gene Silencing
• Stem Cell Reprogramming and Differentiation
• Stable Cell Line Generation
• Therapeutic Delivery
• Bio-Medical Research
• Others

Transfection Technologies Market, By Technology:

• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection

Transfection Technologies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transfection Technologies Market.

Available Customizations:

Global Transfection Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transfection Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection)
  • 5.2.2. By Product (Reagent, Instrument, Others)
  • 5.2.3. By Application (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Others)
  • 5.2.4. By Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Transfection Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Transfection Method
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By Technology
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Transfection Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Transfection Method
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Technology
  • 6.3.2. Canada Transfection Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Transfection Method
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Technology
  • 6.3.3. Mexico Transfection Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Transfection Method
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Technology

7. Europe Transfection Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Transfection Method
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By Technology
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Transfection Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Transfection Method
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Technology
  • 7.3.2. France Transfection Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Transfection Method
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Technology
  • 7.3.3. United Kingdom Transfection Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Transfection Method
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Technology
  • 7.3.4. Italy Transfection Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Transfection Method
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Technology
  • 7.3.5. Spain Transfection Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Transfection Method
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Technology

8. Asia Pacific Transfection Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Transfection Method
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By Technology
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Transfection Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Transfection Method
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Technology
  • 8.3.2. India Transfection Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Transfection Method
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Technology
  • 8.3.3. Japan Transfection Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Transfection Method
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Technology
  • 8.3.4. South Korea Transfection Technologies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Transfection Method
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Technology
  • 8.3.5. Australia Transfection Technologies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Transfection Method
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Technology

9. Middle East & Africa Transfection Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Transfection Method
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By Technology
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Transfection Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Transfection Method
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Technology
  • 9.3.2. UAE Transfection Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Transfection Method
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Technology
  • 9.3.3. South Africa Transfection Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Transfection Method
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Technology

10. South America Transfection Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Transfection Method
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Technology
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Transfection Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Transfection Method
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Technology
  • 10.3.2. Colombia Transfection Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Transfection Method
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Technology
  • 10.3.3. Argentina Transfection Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Transfection Method
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Transfection Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Promega Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Roche Molecular Systems, Inc.
• 15.5. QIAGEN NV
• 15.6. Inovio Pharmaceuticals
• 15.7. Mirus Bio LLC
• 15.8. Takara Bio Inc.
• 15.9. SignaGen Laboratories
• 15.10. MaxCyte, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer